share_log

8-K: Current report

SEC ·  Nov 9, 2024 05:14

Summary by Moomoo AI

Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more